See more : Suraj Products Limited (SURAJ.BO) Income Statement Analysis – Financial Results
Complete financial analysis of CannLabs, Inc. (CANL) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CannLabs, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Big Cheese Studio Spolka Akcyjna (BCS.WA) Income Statement Analysis – Financial Results
- Optimus Finance Limited (OPTIFIN.BO) Income Statement Analysis – Financial Results
- Ubon Bio Ethanol Public Company Limited (UBE.BK) Income Statement Analysis – Financial Results
- Yulon Finance Corporation (9941.TW) Income Statement Analysis – Financial Results
- Aruna Hotels Limited (ARUNAHTEL.BO) Income Statement Analysis – Financial Results
CannLabs, Inc. (CANL)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: http://www.cannlabs.net
About CannLabs, Inc.
CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as education services. CannLabs, Inc. is based in Denver, Colorado.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.39M | 3.18M | 2.77M | 2.50M | 1.36M | 1.36M | 1.36M | 1.36M | 84.30K | 146.15K | 16.16K | 48.50K | 14.19K |
| Cost of Revenue | 2.33M | 1.48M | 1.52M | 1.05M | 886.65K | 886.65K | 2.62M | 886.65K | 109.36 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 2.06M | 1.70M | 1.25M | 1.45M | 478.11K | 478.11K | -1.26M | 478.11K | 84.19K | 146.15K | 16.16K | 48.50K | 14.19K |
| Gross Profit Ratio | 46.97% | 53.39% | 45.05% | 57.90% | 35.03% | 35.03% | -92.26% | 35.03% | 99.87% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 71.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.00M | 141.75K | 140.62K | 0.00 | 81.30K | 15.44K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 661.06K | 3.43 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.19M | 984.04K | 723.67K | 642.50K | 3.67M | 3.67M | 1.93M | 3.67M | 141.75K | 140.62K | 137.67K | 81.30K | 15.44K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.19M | 984.04K | 723.67K | 642.50K | 3.67M | 3.67M | 1.93M | 3.67M | 178.42K | 172.62K | 171.24K | 124.04K | 58.18K |
| Cost & Expenses | 3.52M | 2.47M | 2.24M | 1.69M | 4.55M | 4.55M | 4.55M | 4.55M | 178.42K | 172.62K | 171.24K | 124.04K | 58.18K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 19.00 | 19.00 | 19.00 | 19.00 | 0.00 | 0.00 | 1.29K | 0.00 | 0.00 |
| Interest Expense | 3.07K | 1.51K | 1.53K | 700.00 | 50.20K | 50.20K | 50.20K | 50.20K | 1.22K | 1.31K | 1.52K | 4.19K | 3.66K |
| Depreciation & Amortization | 8.42K | 8.41K | 8.68K | 6.28K | 229.40K | 229.40K | 229.40K | 229.40K | 36.67K | 32.00K | 33.57K | 42.74K | 42.74K |
| EBITDA | 880.66K | 722.71K | 530.78K | 810.56K | -2.96M | -2.96M | -2.96M | -2.96M | -57.45K | 5.53K | -120.23K | -32.80K | -285.00 |
| EBITDA Ratio | 20.05% | 22.72% | 19.19% | 32.44% | -216.76% | -216.76% | -216.76% | -216.76% | -68.15% | 3.78% | -743.93% | -67.63% | -2.01% |
| Operating Income | 872.24K | 714.30K | 522.10K | 804.28K | -3.19M | -3.19M | -3.19M | -3.19M | -77.82K | -26.47K | -155.08K | -75.54K | -43.03K |
| Operating Income Ratio | 19.86% | 22.45% | 18.88% | 32.19% | -233.57% | -233.57% | -233.57% | -233.57% | -92.31% | -18.11% | -959.61% | -155.77% | -303.18% |
| Total Other Income/Expenses | -3.07K | -1.51K | -1.53K | -700.00 | -55.02K | -55.02K | -55.02K | -55.02K | -1.71K | -1.31K | -236.00 | -4.19K | -3.66K |
| Income Before Tax | 869.17K | 712.80K | 520.57K | 803.58K | -3.24M | -3.24M | -3.24M | -3.24M | -79.03K | -27.78K | -155.32K | -79.73K | -46.68K |
| Income Before Tax Ratio | 19.79% | 22.41% | 18.83% | 32.16% | -237.60% | -237.60% | -237.60% | -237.60% | -93.75% | -19.00% | -961.07% | -164.41% | -328.93% |
| Income Tax Expense | 869.17K | 0.00 | 0.00 | 0.00 | -1.66M | -1.66M | -1.66M | -1.61M | 1.22K | 0.00 | 1.29K | 0.00 | 0.00 |
| Net Income | 869.17K | 712.80K | 520.57K | 803.58K | -1.58M | -1.58M | -1.58M | -1.58M | -79.03K | -27.78K | -155.32K | -79.73K | -46.68K |
| Net Income Ratio | 19.79% | 22.41% | 18.83% | 32.16% | -116.08% | -116.08% | -116.08% | -116.08% | -93.75% | -19.00% | -961.07% | -164.41% | -328.93% |
| EPS | 0.00 | 0.00 | 0.00 | 0.01 | -0.03 | -0.03 | -0.03 | -0.03 | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.01 | -0.03 | -0.03 | -0.03 | -0.03 | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 |
| Weighted Avg Shares Out | 813.16M | 813.16M | 463.16M | 62.16M | 60.32M | 60.32M | 60.32M | 60.32M | 54.00M | 16.54M | 16.36M | 15.71M | 15.51M |
| Weighted Avg Shares Out (Dil) | 813.16M | 813.16M | 463.16M | 62.16M | 60.32M | 60.32M | 60.32M | 60.32M | 54.00M | 16.54M | 16.36M | 15.71M | 15.51M |
Source: https://incomestatements.info
Category: Stock Reports